Peter Frampton is heading to the UK for a Farewwell Finale Tour, after which, Frampton plans to retire from regular vigorous touring due to his diagnosis of the autoimmune disease Inclusion Body Myositis (IBM). IBM is a progressive muscle disorder characterized by muscle inflammation, weakness and atrophy.
All Blues (Universal Music) – Frampton’s first-ever blues album with the Peter Frampton Band – continues to receive widespread critical acclaim. The album remained at the number one position on the Billboard Blues Albums Chart for 15 weeks.
Peter Frampton remains one of the most lauded artists in rock history. This year, The Music Business Association presented him with the Chairman’s Award for Sustained Creative Achievement. Frampton was also honoured with the Les Paul Innovation Award at the 2019 NAMM Show’s 34th annual TEC Awards and celebrated the 43rd anniversary of his fifth solo album, Frampton Comes Alive!, one of the top-selling live records of all time (over 17 million copies sold worldwide).